Improved fibrinolytic activity during exercise may be an effect of the adipocyte-derived hormones leptin and adiponectin

Thrombosis Research

Volumn 122, Issue 5, 2008, Pages 701-708

  Eriksson, Maria ^a,b,c   Johnson, Owe ^a,b,c   Boman, Kurt ^a,b,c   Hallmans, Göran ^a,b,c   Hellsten, Gideon ^a,b,c   Nilsson, Torbjörn K ^a,b,c   Söderberg, Stefan ^a,b,c  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c Norsjö District Health Centre   (Sweden)

Author keywords

Adipocyte derived hormones; Adiponectin; Clinical experiment; Fibrinolytic activity; Healthy men; Leptin; Physical activity; Repeated measures

Indexed keywords

ADIPONECTIN; LEPTIN; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADIPOCYTE; ADULT; ANTHROPOMETRY; ARTICLE; EXERCISE; FIBRINOLYSIS; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID DIET; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIING; WAIST CIRCUMFERENCE;

ADIPOCYTES; ADIPONECTIN; ADULT; DIETARY FATS; EXERCISE; FIBRINOLYSIS; HUMANS; LEPTIN; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SKIING;

EID: 49549116886     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.01.010     Document Type: Article

References (55)

1. Reusch J.E. Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome. Am J Cardiol 90 (2002) 19G-26G
2. Diamond Jr. F.B., and Eichler D.C. Leptin and the adipocyte endocrine system. Crit Rev Clin Lab Sci 39 (2002) 499-525
3. Mertens I., and Van Gaal L.F. Obesity, haemostasis and the fibrinolytic system. Obes Rev 3 (2002) 85-101
4. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 189 (2006) 47-60
5. Söderberg S., Ahren B., Jansson J.H., Johnson O., Hallmans G., Asplund K., et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 246 (1999) 409-418
6. Söderberg S., Stegmayr B., Stenlund H., Sjostrom L.G., Agren A., Johansson L., et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med 256 (2004) 128-136
7. Söderberg S., Olsson T., Eliasson M., Johnson O., and Ahren B. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med 245 (1999) 533-543
8. Beltowski J. Adiponectin and resistin-new hormones of white adipose tissue. Med Sci Monit 9 (2003) RA55-RA61
9. Skurk T., van Harmelen V., Lee Y.M., Wirth A., and Hauner H. Relationship between IL- 6, leptin and adiponectin and variables of fibrinolysis in overweight and obese hypertensive patients. Horm Metab Res 34 (2002) 659-663
10. Goldstein B.J., and Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89 (2004) 2563-2568
11. Press V., Freestone I., and George C.F. Physical activity: the evidence of benefit in the prevention of coronary heart disease. QJM 96 (2003) 245-251
12. Schuit A.J., Schouten E.G., Kluft C., de Maat M., Menheere P.P., and Kok F.J. Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderly men and women. Thromb Haemost 78 (1997) 845-851
13. Gomez-Merino D., Chennaoui M., Drogou C., Bonneau D., and Guezennec C.Y. Decrease in serum leptin after prolonged physical activity in men. Med Sci Sports Exerc 34 (2002) 1594-1599
14. Ring-Dimitriou S., Paulweber B., von Duvillard S.P., Stadlmann M., LeMura L.M., Lang J., et al. The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome. Eur J Appl Physiol 98 (2006) 472-481
15. Weiss E.P., Racette S.B., Villareal D.T., Fontana L., Steger-May K., Schechtman K.B., et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr 84 (2006) 1033-1042
16. Boman K., Hellsten G., Bruce A., Hallmans G., and Nilsson T.K. Endurance physical activity, diet and fibrinolysis. Atherosclerosis 106 (1994) 65-74
17. Margetic S., Gazzola C., Pegg G.G., and Hill R.A. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26 (2002) 1407-1433
18. Lihn A.S., Pedersen S.B., and Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6 (2005) 13-21
19. Zheng D., Wooter M.H., Zhou Q., and Dohm G.L. The effect of exercise on ob gene expression. Biochem Biophys Res Commun 225 (1996) 747-750
20. Pagano C., Marzolo M., Granzotto M., Ricquier D., Federspil G., and Vettor R. Acute effects of exercise on circulating leptin in lean and genetically obese fa/fa rats. Biochem Biophys Res Commun 255 (1999) 698-702
21. Perusse L., Collier G., Gagnon J., Leon A.S., Rao D.C., Skinner J.S., et al. Acute and chronic effects of exercise on leptin levels in humans. J Appl Physiol 83 (1997) 5-10
22. Racette S.B., Coppack S.W., Landt M., and Klein S. Leptin production during moderate-intensity aerobic exercise. J Clin Endocrinol Metab 82 (1997) 2275-2277
23. Duclos M., Corcuff J.B., Ruffie A., Roger P., and Manier G. Rapid leptin decrease in immediate post-exercise recovery. Clin Endocrinol (Oxf) 50 (1999) 337-342
24. Keller P., Keller C., Steensberg A., Robinson L.E., and Pedersen B.K. Leptin gene expression and systemic levels in healthy men: effect of exercise, carbohydrate, interleukin-6, and epinephrine. J Appl Physiol 98 (2005) 1805-1812
25. Hulver M.W., and Houmard J.A. Plasma leptin and exercise: recent findings. Sports Med 33 (2003) 473-482
26. Hulver M.W., Zheng D., Tanner C.J., Houmard J.A., Kraus W.E., Slentz C.A., et al. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283 (2002) E861-E865
27. Polak J., Klimcakova E., Moro C., Viguerie N., Berlan M., Hejnova J., et al. Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women. Metabolism 55 (2006) 1375-1381
28. Fatouros I.G., Tournis S., Leontsini D., Jamurtas A.Z., Sxina M., Thomakos P., et al. Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. J Clin Endocrinol Metab 90 (2005) 5970-5977
29. Jansson J.H., Olofsson B.O., and Nilsson T.K. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation 88 (1993) 2030-2034
30. Thøgersen A.M., Jansson J.H., Boman K., Nilsson T.K., Weinehall L., Huhtasaari F., et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 98 (1998) 2241-2247
31. Arnman V., Nilsson A., Stemme S., Risberg B., and Rymo L. Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins. Thromb Res 76 (1994) 487-499
32. Robbie L.A., Booth N.A., Brown A.J., and Bennett B. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler Thromb Vasc Biol 16 (1996) 539-545
33. Leosco D., Iaccarino G., Cipolletta E., De Santis D., Pisani E., Trimarco V., et al. Exercise restores beta-adrenergic vasorelaxation in aged rat carotid arteries. Am J Physiol Heart Circ Physiol 285 (2003) H369-H374
34. Gardner A.W., and Killewich L.A. Association between physical activity and endogenous fibrinolysis in peripheral arterial disease: a cross-sectional study. Angiology 53 (2002) 367-374
35. Ivey F.M., Womack C.J., Kulaputana O., Dobrovolny C.L., Wiley L.A., and Macko R.F. A single bout of walking exercise enhances endogenous fibrinolysis in stroke patients. Med Sci Sports Exerc 35 (2003) 193-198
36. Hambrecht R., Adams V., Erbs S., Linke A., Krankel N., Shu Y., et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 107 (2003) 3152-3158
37. Szymanski L.M., and Pate R.R. Effects of exercise intensity, duration, and time of day on fibrinolytic activity in physically active men. Med Sci Sports Exerc 26 (1994) 1102-1108
38. Lindahl B., Nilsson T.K., Jansson J.H., Asplund K., and Hallmans G. Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med 246 (1999) 105-112
39. Sesso H.D., Paffenbarger Jr. R.S., and Lee I.M. Physical activity and coronary heart disease in men: the Harvard Alumni Health Study. Circulation 102 (2000) 975-980
40. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
41. Ribeiro J., Almeida-Dias A., Ascensao A., Magalhaes J., Oliveira A.R., Carlson J., et al. Hemostatic response to acute physical exercise in healthy adolescents. J Sci Med Sport 10 (2007) 164-169
42. Weiss C., Seitel G., and Bartsch P. Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 30 (1998) 246-251
43. Hosoi M., Yamakawa K., Koyama H., Fukumoto S., Inaba M., Okuno Y., et al. Leptin increases plasminogen activator inhibitor-1 (PAI-1) production in human vascular smooth muscle cell (Abstract 463). Diabetes 47 (1998) A118
44. Aprath-Husmann I., Rohrig K., Gottschling-Zeller H., Skurk T., Scriba D., Birgel M., et al. Effects of leptin on the differentiation and metabolism of human adipocytes. Int J Obes Relat Metab Disord 25 (2001) 1465-1470
45. van Hinsbergh V.W., Binnema D., Scheffer M.A., Sprengers E.D., Kooistra T., and Rijken D.C. Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels. Arteriosclerosis 7 (1987) 389-400
46. Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48 (1999) 903-908
47. Knudson J.D., Dincer U.D., Zhang C., Swafford Jr. A.N., Koshida R., Picchi A., et al. Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 289 (2005) H48-H56
48. De Mitrio V., De Pergola G., Vettor R., Marino R., Sciaraffia M., Pagano C., et al. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women. Metabolism 48 (1999) 960-964
49. Sudi K.M., Gallistl S., Weinhandl G., Muntean W., and Borkenstein M.H. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism 49 (2000) 890-895
50. Maruyoshi H., Kojima S., Funahashi T., Miyamoto S., Hokamaki J., Soejima H., et al. Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina. Thromb Haemost 91 (2004) 1026-1030
51. Shetty G.K., Economides P.A., Horton E.S., Mantzoros C.S., and Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27 (2004) 2450-2457
52. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
53. Lindsay R.S., Resnick H.E., Zhu J., Tun M.L., Howard B.V., Zhang Y., et al. Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol 25 (2005) e15-e16
54. Free shareware: PS - Power and Sample Size Calculation. Version 2.1.31, 2004. Last accessed November 26, 2007. http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/PowerSampleSize
55. Sopasakis V.R., Nagaev I., and Smith U. Cytokine release from adipose tissue of nonobese individuals. Int J Obes (Lond) 29 (2005) 1144-1147